Topics

Real-World Evidence: Sponsors Look To US FDA Drug Reviews For Potential Pitfalls

15:28 EDT 7 Oct 2019 | SCRIP

Methodological problems with RWE submissions for approved applications may give sponsors ‘a little bit of a pause’ as they work...

      

Related Stories

 

Original Article: Real-World Evidence: Sponsors Look To US FDA Drug Reviews For Potential Pitfalls

NEXT ARTICLE

More From BioPortfolio on "Real-World Evidence: Sponsors Look To US FDA Drug Reviews For Potential Pitfalls"

Quick Search